The tumor suppressor role of PAQR3 in osteosarcoma

Tumor Biology

Volumn 36, Issue 5, 2015, Pages 3319-3324

  Ma, Zhiqiang ^a   Wang, Yanlong ^a   Piao, Taikui ^b   Li, Zhaopeng ^a   Zhang, Hongyu ^a   Liu, Zhixin ^a   Liu, Jianyu ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Children's Hospital 150020   (China)

Author keywords

ERK1 2; Osteosarcoma; PAQR3; Tumor suppressor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MITOGEN ACTIVATED PROTEIN KINASE; PAQR3 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; RKTG PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BONE TUMOR; CELL MOTION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84929965893     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2964-z     Document Type: Article

References (26)

1. Rainusso N, Wang LL, Yustein JT. The adolescent and young adult with cancer: State of the art bone tumors. Curr Oncol Rep. 2013;15:296–307.
2. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, et al. Modulation of the osteosarcoma expression phenotype by micrornas. PLoS One. 2012;7:e48086.
3. Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X, et al. Mir-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of ezrin in f5m2 cells. Int J Mol Med. 2012;30:1013–20.
4. Yang J, Zhang W. New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol. 2013;25:398–406.
5. Cai H, Lin L, Tang M, Wang Z. Prognostic evaluation of microrna-210 expression in pediatric osteosarcoma. Med Oncol. 2013;30:499.
6. Chung JY, Kim JD, Park GH, Jung ST, Lee KB: Occipito-cervical reconstruction through direct lateral and posterior approach or the treatment of primary osteosarcoma in the atlas: a case report. Spine. 2011.
7. Liang W, Gao B, Fu P, Xu S, Qian Y, Fu Q. The mirnas in the pathogenesis of osteosarcoma. Front Biosci (Landmark Ed). 2013;18:788–94.
8. He C, Xiong J, Xu X, Lu W, Liu L, Xiao D, et al. Functional elucidation of mir-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun. 2009;388:35–40.
9. Cai CK, Zhao GY, Tian LY, Liu L, Yan K, Ma YL, et al. Mir-15a and mir-16-1 downregulate ccnd1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncol Rep. 2012;28:1764–70.
10. Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X, et al. Down-regulation of mir-183 promotes migration and invasion of osteosarcoma by targeting ezrin. Am J Pathol. 2012;180:2440–51.
11. Kelly AD, Haibe-Kains B, Janeway KA, Hill KE, Howe E, Goldsmith J, et al. Microrna paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32. Genome Med. 2013;5:2.
12. Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, Yoshioka Y, et al. Microrna-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther: J Am Soc Gene Ther. 2011;19:1123–30.
13. Zhou X, Wei M, Wang W. Microrna-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting rock1. Biochem Biophys Res Commun. 2013;437:653–8.
14. Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q, et al. Microrna-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One. 2012;7:e33778.
15. Fan L, Wu Q, Xing X, Wei Y, Shao Z. Microrna-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells. Acta Biochim Biophys Sin. 2012;44:407–14.
16. Wang L, Wang X, Li Z, Xia T, Zhu L, Liu B, et al. Paqr3 has modulatory roles in obesity, energy metabolism, and leptin signaling. Endocrinology. 2013;154:4525–35.
17. Wang X, Wang L, Zhu L, Pan Y, Xiao F, Liu W, et al. Paqr3 modulates insulin signaling by shunting phosphoinositide 3-kinase p110alpha to the golgi apparatus. Diabetes. 2013;62:444–56.
18. Zhang Y, Jiang X, Qin X, Ye D, Yi Z, Liu M, et al. Rktg inhibits angiogenesis by suppressing mapk-mediated autocrine vegf signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene. 2010;29:5404–15.
19. Wang X, Li X, Fan F, Jiao S, Wang L, Zhu L, et al. Paqr3 plays a suppressive role in the tumorigenesis of colorectal cancers. Carcinogenesis. 2012;33:2228–35.
20. Ling ZQ, Guo W, Lu XX, Zhu X, Hong LL, Wang Z, et al. A golgi-specific protein paqr3 is closely associated with the progression, metastasis and prognosis of human gastric cancers. Ann Oncol: Off J Eur Soc Med Oncol / ESMO. 2014;25:1363–72.
21. Wu HG, Zhang WJ, Ding Q, Peng G, Zou ZW, Liu T, et al. Identification of paqr3 as a new candidate tumor suppressor in hepatocellular carcinoma. Oncol Rep. 2014;32:2687–95.
22. Saldana-Meyer R, Recillas-Targa F. Transcriptional and epigenetic regulation of the p53 tumor suppressor gene. Epigenetics: Off J DNA Methylation Soc. 2011;6:1068–77.
23. Lee SH, Ju SK, Lee TY, Huh SH, Han KH. Tip30 directly binds p53 tumor suppressor protein in vitro. Mol Cells. 2012;34:495–500.
24. Volodko N, Gordon M, Salla M, Ghazaleh HA, Baksh S: Rassf tumor suppressor gene family: Biological functions and regulation. FEBS Lett. 2014.
25. Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, et al. Mir-152 is a tumor suppressor microrna that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res. 2011;71:6450–62.
26. Zhang Y, Cai X, Schlegelberger B, Zheng S. Assignment1 of human putative tumor suppressor genes st13 (alias snc6) and st14 (alias snc19) to human chromosome bands 22q13 and 11q24– > q25 by in situ hybridization. Cytogenet Cell Genet. 1998;83:56–7.